Insider Selling: Aflac Incorporated (NYSE:AFL) Director Sells 1,000 Shares of Stock

Aflac Incorporated (NYSE:AFL) Director Joseph L. Moskowitz sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $107.63, for a total transaction of $107,630.00. Following the completion of the transaction, the director now owns 25,393 shares in the company, valued at approximately $2,733,048.59. This represents a 3.79 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Aflac Price Performance

Shares of Aflac stock opened at $104.95 on Friday. The stock has a market cap of $57.37 billion, a P/E ratio of 10.93, a P/E/G ratio of 3.24 and a beta of 0.93. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. The stock’s fifty day moving average is $105.29 and its 200 day moving average is $107.69. Aflac Incorporated has a one year low of $79.31 and a one year high of $115.50.

Aflac (NYSE:AFL) last posted its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. Sell-side analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current year.

Hedge Funds Weigh In On Aflac

Several large investors have recently added to or reduced their stakes in AFL. Vanguard Group Inc. increased its stake in shares of Aflac by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 51,340,298 shares of the financial services provider’s stock worth $5,310,640,000 after purchasing an additional 653,275 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of Aflac by 2.4% during the 4th quarter. Geode Capital Management LLC now owns 12,465,433 shares of the financial services provider’s stock valued at $1,286,042,000 after buying an additional 288,482 shares in the last quarter. Northern Trust Corp boosted its holdings in Aflac by 22.9% in the 4th quarter. Northern Trust Corp now owns 7,296,014 shares of the financial services provider’s stock worth $754,700,000 after buying an additional 1,357,753 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Aflac by 11.9% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,250,905 shares of the financial services provider’s stock worth $543,154,000 after buying an additional 556,394 shares in the last quarter. Finally, Norges Bank bought a new stake in Aflac during the fourth quarter valued at about $349,699,000. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the company. JPMorgan Chase & Co. boosted their price target on Aflac from $90.00 to $94.00 and gave the stock a “neutral” rating in a research note on Tuesday, January 7th. Evercore ISI lowered their target price on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a research note on Wednesday, December 4th. Keefe, Bruyette & Woods reduced their price target on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a research note on Wednesday, February 12th. StockNews.com raised shares of Aflac from a “sell” rating to a “hold” rating in a report on Friday, February 14th. Finally, Morgan Stanley raised their target price on shares of Aflac from $98.00 to $105.00 and gave the stock an “equal weight” rating in a report on Friday, February 28th. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat, Aflac currently has a consensus rating of “Hold” and an average price target of $103.36.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.